Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Clift, J. Hansen, E. Thomas, C. Buckner, J. Sanders, E. Mickelson, R. Storb, F. Johnson, J. Singer, B. Goodell (1979)
Marrow transplantation from donors other than HLA-identical siblings.Transplantation, 28 3
R. Storb, P. Weiden, H. Deeg, Beverly Torok-Storb, K. Atkinson, T. Graham, Thomas Ed (1980)
Marrow graft studies in dogs.Haematology and blood transfusion, 25
J. Woods, C. Anderson, J. DeWeerd, W. Johnson, J. Donadio, F. Leary, P. Frohnert (1973)
High-dosage intravenously administered methylprednisolone in renal transplantation. A preliminary report.JAMA, 223 8
R. Slavin, G. Santos (1973)
The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication.Clinical immunology and immunopathology, 1 4
H. Shulman, G. McDonald, David Matthews, K. Doney, K. Kopecky, Jean Gauvreau, E. Thomas (1980)
An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation.Gastroenterology, 79 6
E. Gluckman, A. Devergie, G. Schaison, A. Bussel, R. Berger, J. Sohier, J. Bernard (1980)
Bone Marrow Transplantation in Fanconi AnaemiaBritish Journal of Haematology, 45
P. Weiden, K. Doney, R. Storb, Thomas Ed (1979)
ANTIHUMAN THYMOCYTE GLOBULIN FOR PROPHYLAXIS OF GRAFT‐VERSUS-HOST DISEASE: A RANDOMIZED TRIAL IN PATIENTS WITH LEUKEMIA TREATED WITH HLA‐IDENTICAL SIBLING MARROW GRAFTSTransplantation, 27
R. Storb, E. Gluckman, Thomas Ed, Buckner Cd, R. Cliff, A. Fefer, H. Glucksberg, T. Graham, F. Johnson, Lerner Kg, P. Neiman, Ochs Hd (1974)
Treatment of established human graft-versus-host disease by antithymocyte globulin.Blood, 44 1
K. Doney, K. Doney, P. Weiden, R. Storb, Thomas Ed (1981)
Treatment of graft‐versus‐host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroidsAmerican Journal of Hematology, 11
R. Powles, H. Clink, J. Sloane, A. Barrett, H. Kay, T. Mcelwain (1978)
CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MANThe Lancet, 312
A. Bacigalupo, M. Lint, R. Cerri (1980)
Treatment of severe aplastic anemia with bolus 6-methylprednisolone and antilymphocytic globulinAnnals of Hematology, 41
J. Trotter, William Gamey (1980)
Prolonged effects of large‐dose methylprednisolone infusion in multiple sclerosisNeurology, 30
Eliane Gluckrnan, Arleen, Auerbach, M. Horowitz, K. Sobocinski, R. Ash, M. Bortin, A. Butturini, Bruce Carnitta, Richard Charnplin, Wilhelrn Friedrich, R. Good, E. Gordon-Smith, R. Harris, J. Klein, Juan, Ortega, R. Pasquini, Norma Rarnsay, B. Speck, M. Vowels, Mei-Jie Zhang, R. Gale (1995)
Bone marrow transplantation for Fanconi anemia.Blood, 86 7
A. Bacigalupo, M. Lint, C. Volta, G. Grazi, O. Soro, M. Podestà, F. Frassoni, A. Marmont (1981)
Tobramycin versus Gentamicin, in Combination with Cephalotin and Carbenecillin, in Patients Undergoing Bone Marrow TransplantationTumori Journal, 67
A. Marmont (1979)
Transplantation haemopoiesis. Morphological bone marrow studies after allogeneic marrow transplantation in man for severe aplastic anaemia and acute leukaemia.Nouvelle revue francaise d'hematologie, 21 2
(1980)
Prophylaxis of graft versus host disease with cyelosporin A
R. Storb, R. Prentice, Thomas Ed (1977)
Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival.The Journal of clinical investigation, 59 4
J. Hansen, J. Hansen, R. Clift, R. Clift, E. Mickelson, E. Mickelson, B. Nisperos, B. Nisperos, Thomas Ed, Thomas Ed (1981)
Marrow transplantation from donors other than HLA identical siblings.Human immunology, 2 1
R. Powles, H. Clink, D. Spence, G. Morgenstern, J. Watson, P. Selby, M. Woods, A. Barrett, B. Jameson, J. Sloane, S. Lawler, H. Kay, D. Lawson, T. Mcelwain, P. Alexander (1980)
CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 315
R. Storb, R. Epstein, T. Graham, E. Thomas (1970)
METHOTREXATE REGIMENS FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGS WITH ALLOGENEIC MARROW GRAFTSTransplantation, 9
H. Glucksberg, R. Storb, A. Fefer, Buckner Cd, P. Neiman, R. Clift, Lerner Kg, Thomas Ed (1974)
CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,STransplantation, 18
P. Weiden, K. Doney, R. Storb, E. Thomas (1978)
Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts.Transplantation proceedings, 10 1
Van Dw (1974)
The double barrier in bone marrow transplantation.Seminars in Hematology, 11
Susan Zimmerman, Terrie Cohen, Ruth Diekman, CANDICE Calvo, Maribeth Hangsterfer (1977)
Bone marrow transplantation.The American journal of nursing, 77 8
(1980)
High dose methylprednisolone therapy in established acute graft versus host disease
A. Marmont, E. Damasio, A. Bacigalupo, D. Giordano, E. Rossi, G. Reali, A. Gay, F. Dagna‐Bricarelli, F. Brema, A. Carella, G. Santini (1977)
A to O Bone Marrow Transplantation in Severe Aplastic Anaemia: Dynamics of Blood Group Conversion and Demonstration of Early Dyserythropoiesis in the Engrafted MarrowBritish Journal of Haematology, 36
A. Owens, G. Santos (1971)
THE EFFECT OF CYTOTOXIC DRUGS ON GRAFT‐VERSUS-HOST DISEASE IN MICETransplantation, 11
M. Simonsen (1962)
Graft versus host reactions. Their natural history, and applicability as tools of research.Progress in allergy, 6
E. Gluckman, A. Barrett, W. Arcese, A. Devergie, P. Degoulet (1981)
Bone Marrow Transplantation in Severe Aplastic Anaemia: a Survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.) *British Journal of Haematology, 49
W. Bolton, W. Couser (1979)
Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis.The American journal of medicine, 66 3
B. Darlow, G. Abbott, M. Beard, H. Fox, J. Hamer, D. Heaton (1980)
Bone marrow transplantation for severe aplastic anaemia.The New Zealand medical journal, 91 653
(1975)
Bone-marrow transplantation (first of two parts).The New England journal of medicine, 292 16
277 46 46 3 3 Andrea Bacigalupo Maria T. van Lint Francesco Frassoni Marina Podesta Giovanna Veneziano Giorgio Avanzi Vito Vitale Alberto M. Marmont Department of Hematology Ospedale San Martino 1-16132 Genova Italy Summary Nineteen patients with acute graft versus host disease (GvHD) following bone marrow transplantation (BMT) were treated with high dose bolus 6-methylprednisolone (BMPr), at the dose of 20 mg/kg/day i.v. for the first 3 days, 10 mg/kg/day i.v. for the following 4 days, and then at doses gradually tapered down to 1 mg/kg/day. All patients except one, who was given preventive BMPr 5 mg/kg/day i.v. on alternate days, were placed on preventive methotrexate therapy after BMT. Sixteen patients were grafted with an HLA matched, and three patients with an HLA mismatched marrow. Overall complete response rate in the HLA matched group was 43%, with an additional 50% showing a partial response. In the HLA mismatched group there were no responses and all three patients proved refractory to BMPr. With respect to organ involvement the complete and partial response rates were respectively 50% and 33% in the skin, 36% and 28% in the liver, 18% and 55% in the gut. Six of sixteen patients in the HLA matched group and none of the three in the HLA mismatched group are surviving. Thirteen patients died: nine patients for causes directly or indirectly related to GvHD, four of other causes (relapse, rejection, hemorrhage and idiopathic interstitial pneumonia). Side effects of BMPr consisted in hyperglicemia, and steroid associated gastritis in 2/3 of the patients, both of which responded well to conventional treatment. This study indicates that high dose BMPr is an effective form of treatment for established acute GvHD, and has no major side effects. The efficacy of BMPr is less clear in recipients of HLA mismatched grafts.
Annals of Hematology – Springer Journals
Published: Mar 1, 1983
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.